Regulatory
Now alerts Amazon about deceptive certificates of analysis used by seller on its site
June 28th 2022Now has notified Amazon about a brand posting Certificates of Analysis from a third-party testing lab on their website which confirm the fill weight of its products, but not the identity, potency, or purity.
Annual pediatric melatonin ingestion up 530% between 2012 and 2021, says CDC report
June 7th 2022The report assessed isolated melatonin ingestions among children, adolescents, and young adults 19 years and under between January 1, 2012, and December 31, 2021 using the American Association of Poison Control Centers’ National Poison Data System (NPDS).
NAD recommends Goli modify, discontinue claims connected to its Ashwagandha Gummies
June 1st 2022The National Advertising Division of BBB National Programs recommended Goli discontinue claims regarding sexual function, weight loss and management, and physical performance after reviewing Goli’s evidence and determining that much of it was not sufficient to support its claims.
AHPA submits comments on mandatory product listing language in FDASLA
May 25th 2022While affirming opposition to mandatory product listing, the American Herbal Products Association offered its feedback and suggested revisions to the discussion draft of the FDA Safety and Landmark Advancements (FDASLA) Act published by the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP).